Atara Biotherapeutics, Inc. Class Action Lawsuit
Company: Atara Biotherapeutics, Inc.
Ticker: (NASDAQ) ATRA
Class Action Period: May 20, 2024 - January 9, 2026
See If You Qualify For Monetary Reward
Join the Atara Biotherapeutics, Inc. Class Action Lawsuit
CLASS ACTION PERIOD
May 20, 2024 - January 9, 2026
Allegations
The complaint filed against Atara Biotherapeutics, Inc. alleges the company made statements that were materially false and/or misleading and/or failed to disclose that: (i) certain manufacturing issues, as well as deficiencies inherent in the ALLELE study, made it unlikely that the FDA would approve the tabelecleucel BLA; (ii) accordingly, tabelecleucel’s regulatory prospects were overstated; (iii) the aforementioned manufacturing issues also subjected Atara to a heightened risk of regulatory scrutiny, as well as jeopardized its ongoing clinical trials; (iv) all the foregoing was likely to have a significant negative impact on Atara’s business and financial condition; and (v) as a result, defendants’ public statements were materially false and/or misleading at all relevant times.
Eligibility
To join the lawsuit, you must have experienced a loss on Atara Biotherapeutics, Inc. shares purchased within the class period specified above.
Lead Plaintiff Deadline
If you suffered a loss in Atara Biotherapeutics, Inc. during the relevant time frame, you have until May 22, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Frequently Asked Questions
- How do I join the lawsuit against Atara Biotherapeutics, Inc. (NASDAQ: ATRA)?
Investors who purchased shares of Atara Biotherapeutics, Inc. (NASDAQ: ATRA) during the class period (May 20, 2024 - January 9, 2026) can join by submitting their transaction details through this case page.
- Ensure your purchase falls within the class period
- Provide basic transaction and loss details
- Submit your information before the deadline
The lead plaintiff deadline for this case is May 22, 2026, so investors should act quickly to protect their rights.
- Who is eligible for the Atara Biotherapeutics, Inc. lawsuit?
Anyone who bought shares of Atara Biotherapeutics, Inc. (NASDAQ: ATRA) during May 20, 2024 - January 9, 2026 and suffered financial losses may qualify.
- What is the lead plaintiff deadline to join the Atara Biotherapeutics, Inc. case?
The lead plaintiff deadline for the Atara Biotherapeutics, Inc. lawsuit is May 22, 2026. Investors should act quickly to avoid missing this deadline.
- What is the class period for Atara Biotherapeutics, Inc.?
The class period for Atara Biotherapeutics, Inc. (NASDAQ: ATRA) is May 20, 2024 - January 9, 2026, during which investors may have been affected by alleged misconduct.
- Can I still join the Atara Biotherapeutics, Inc. lawsuit if I sold my shares?
Yes. Investors who purchased Atara Biotherapeutics, Inc. shares during May 20, 2024 - January 9, 2026 may still qualify, even if they sold their shares later.
- How much compensation can I receive from the Atara Biotherapeutics, Inc. lawsuit?
Compensation depends on the total losses and the final settlement. Eligible investors in the Atara Biotherapeutics, Inc. case may receive a portion of the recovery.
- Do I need to pay to participate in the Atara Biotherapeutics, Inc. case?
No, most securities fraud cases involving Atara Biotherapeutics, Inc. operate on a contingency basis, meaning there are no upfront costs unless there is a recovery.
- Will I need to appear in court for the Atara Biotherapeutics, Inc. lawsuit?
In most cases, investors do not need to appear in court. The legal team manages the Atara Biotherapeutics, Inc. case on behalf of participants.
- What documents are required for the Atara Biotherapeutics, Inc. lawsuit?
To participate in the Atara Biotherapeutics, Inc. lawsuit, investors may need to provide transaction records, purchase dates, number of shares, and loss details.
- What happens after I submit my trade information for Atara Biotherapeutics, Inc.?
After submission, your details for the Atara Biotherapeutics, Inc. case will be reviewed, and you may be contacted regarding eligibility or next steps.
- Is this legal advice for the Atara Biotherapeutics, Inc. lawsuit?
No, this page provides information about the Atara Biotherapeutics, Inc. case and does not constitute legal advice or create an attorney-client relationship.
- Why should I act quickly on the Atara Biotherapeutics, Inc. case?
The lead plaintiff deadline for the Atara Biotherapeutics, Inc. lawsuit is May 22, 2026. If you are an investor, you may have the opportunity to seek appointment as lead plaintiff or remain an absent class member.
EXPLORE MORE CASES
Snowflake Inc.
SNOW
Lead Plaintiff Deadline: April 27, 2026
Class Period: June 27, 2023 - February 28, 2024
Enphase Energy, Inc.
ENPH
Lead Plaintiff Deadline: April 20, 2026
Class Period: April 22, 2025 - October 28, 2025